title: Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron.
abstract: The aim of the present study was to develop a transdermal drug delivery system for azasetron and evaluate the correlation between in vitro and in vivo release. The effects of different adhesives, permeation enhancers, and loadings of azasetron used in patches on the penetration of azasetron through rabbit skin were investigated using two-chamber diffusion cells in vitro. For in vivo studies, azasetron pharmacokinetic parameters in Bama miniature pigs were determined according to a noncompartment model method after topical application of transdermal patches and intravenous administration of azasetron injections. The best permeation profile was obtained with the formulation containing DURO-TAK 87-9301 as adhesive, 5% of isopropyl myristate as penetration enhancer, and 5% of azasetron. The optimal patch formulation exhibited sustained release profiles in vivo for 216 h. The in vivo absorption curve in Bama miniature pigs obtained by deconvolution approach using WinNonlin® program was correlated well with the in vitro permeation curve of the azasetron patch. These findings indicated that the developed patch for azasetron is promising for the treatment of delayed chemotherapy-induced nausea and vomiting, and the in vitro skin permeation experiments could be useful to predict the in vivo performance of transdermal azasetron patches.
authors.affiliation: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Sun
authors.forename: Dongmei
authors.initials: D
authors.lastname: Cun
authors.forename: Bo
authors.initials: B
authors.lastname: Yuan
authors.forename: Hongxia
authors.initials: H
authors.lastname: Cui
authors.forename: Honglei
authors.initials: H
authors.lastname: Xi
authors.forename: Liwei
authors.initials: L
authors.lastname: Mu
authors.forename: Yang
authors.initials: Y
authors.lastname: Chen
authors.forename: Chao
authors.initials: C
authors.lastname: Liu
authors.forename: Zhongyan
authors.initials: Z
authors.lastname: Wang
authors.forename: Liang
authors.initials: L
authors.lastname: Fang
mesh_terms: D000269:Adhesives / Q000737:chemistry; D000818:Animals; D000932:Antiemetics / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D010078:Oxazines / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D011817:Rabbits; D012867:Skin / Q000378:metabolism; D013552:Swine; D013556:Swine, Miniature; D057968:Transdermal Patch
chemical_list: D000269:Adhesives; D000932:Antiemetics; D019086:Bridged Bicyclo Compounds, Heterocyclic; D010078:Oxazines; C070671:azasetron